o2h ventures backed Small Pharma receives approval for world’s first DMT for depression clinical trial
- On February 22, 2021
- By GrowthInvest Marketing
Small Pharma receives regulatory approval for clinical trial to explore DMT for depression, which it claims is the world’s first patient clinical trial of the psychedelic.
GET IN TOUCH!
CALL US020 7071 3945
FOLLOW US ON
Throughout our site you will find links to external websites. Although we make every effort to ensure these links are accurate, up to date and relevant, we cannot take responsibility for pages maintained by external providers.